Healthy People 2010 Focus Area 4:

Chronic Kidney Disease

Progress ReviewSeptember 21, 2006

4-1. End-stage renal disease 4-2. Cardiovascular disease deaths in persons with chronic

kidney failure4-3. Counseling for chronic kidney failure care 4-4. Use of arteriovenous fistulas4-5. Registration for kidney transplantation4-6. Waiting time for kidney transplantation4-7. End-stage renal disease due to diabetes4-8a. Medical evaluation for persons with type 1 or type 2 diabetes and chronic kidney disease4-8b. Medical treatment for persons with type 1 or type 2 diabetes and chronic kidney disease

Status of Chronic Kidney Disease Objectives

Improving Getting worse

Baseline data onlyTarget met

End-stage Renal Disease, By Race/Hispanic Origin

Obj. 4-1Note: American Indian includes Alaska Native. Asian includes Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: United States Renal Data System (USRDS), NIH, NIDDK.

Asian

Incidence rate per 1,000,000 population

1999 2000 2001 2002 2003

2010 Target

Total White

Black

Hispanic

American Indian

19981997 2004

1,200

1,000

800

600

400

200

0

End-stage Renal Disease Due to Diabetes,

By Race/Hispanic Origin

Obj. 4-7Note: American Indian includes Alaska Native. Asian includes Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: United States Renal Data System (USRDS), NIH, NIDDK.

Asian

Incidence rate per 1,000,000 population

1999 2000 2001 2002 2003

2010 Target

Total White

Black

Hispanic

American Indian

19981997 2004

1,200

1,000

800

600

400

200

0

Asian

1999 2000 2001 2002 2003

TotalWhite

Black

Hispanic

American Indian

1998

1997 2004

1,200

1,000

800

600

400

0

ESRD and ESRD Due to Diabetes,By Race/Hispanic Origin

Incidence rate per million

1999 2000 2001 2002 20031998

1997 2004

1,200

1,000

800

600

400

200

0

Asian

2010 Target

Total

Black

Hispanic

American Indian

200White

Obj. 4-1

Note: American Indian includes Alaska Native. Asian includes Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: United States Renal Data System (USRDS), NIH, NIDDK.

Obj. 4-7

End-stage Renal Disease End-stage Renal DiseaseDue to Diabetes

2010 Target

End-stage Renal Disease, By Race and Gender

Incidence rate per 1,000,000

Obj. 4-1Note: American Indian includes Alaska Native. Asian includes Pacific Islander. SOURCE: United States Renal Data System (USRDS), NIH, NIDDK.

Men

Women

Asian

American Indian

Black

White

Asian

American Indian

Black

White

1,2001,0008006004002000

1998-2000 2001-2003

2010 Target

End-stage Renal Disease, By Health Service Area, 1993Incidence rate per 1,000,000

population

Obj. 4-1SOURCE: United States Renal Data System (USRDS), NIH, NIDDK.

End-stage Renal Disease, By Health Service Area, 2003Incidence rate per 1,000,000

population

Obj. 4-1SOURCE: United States Renal Data System (USRDS), NIH, NIDDK.

Males

End-stage Renal Disease Due to Diabetes,

By GenderIncidence rate per 1,000,000 population

2010 Target

Total

Females

Obj. 4-7SOURCE:United States Renal Data System (USRDS), NIH, NIDDK.

1999 2000 2001 2002 200319981997 2004

200

180

160

140

120

100

80

60

40

20

0

Asian

Use of Arteriovenous Fistulas* Among the Newly Diagnosed

By Race/Hispanic OriginPercent

1999 2000 2001 2002 2003

2010 Target

Total

White

Black

Hispanic

American Indian

Obj. 4-4

Note: American Indian includes Alaska Native. Asian includes Pacific Islander. The categories black and white exclude persons of Hispanic origin. Persons of Hispanic origin may be any race. SOURCE: Centers for Medicare and Medicaid Services (CMS) Clinical Performace Measures (CPM) project.

1998

50

60

40

30

20

10

0

70

80

Females

Use of Arteriovenous Fistulas Among the Newly Diagnosed

By GenderPercent

1999 2000 2001 2002 2003

2010 Target

TotalMales

Obj. 4-4SOURCE: Centers for Medicare and Medicaid Services (CMS) Clinical Performance Measures (CPM) project.

1998

50

60

40

30

20

10

0

Percent

2010 Target

Obj. 4-8a

2000 2001 2002 2003 2004Note: American Indian includes Alaska Native; Native Hawaiian includes other Pacific Islander. Persons of Hispanic origin may be any race. Only one race category could be recorded. Recording more than one race was not an option.SOURCE: Centers for Medicare and Medicaid Services (CMS); United States Renal Data System (USRDS), NIH, NIDDK.

AsianWhite

Black

Hispanic

American Indian

50

60

40

30

20

10

0

Medical Evaluation for Persons with Diabetes and Chronic Kidney Disease

Percent

2010 Target

Obj. 4-8a

2000 2001 2002 2003 2004Note: American Indian includes Alaska Native; Native Hawaiian includes other Pacific Islander. Persons of Hispanic origin may be any race. Only one race category could be recorded. Recording more than one race was not an option.SOURCE: Centers for Medicare and Medicaid Services (CMS); United States Renal Data System (USRDS), NIH, NIDDK.

AsianWhite

Black

Hispanic

American Indian

50

60

40

30

20

10

0

Medical Evaluation for Persons with Diabetes and Chronic Kidney Disease

Medical evaluation include eye examinations, lipid testing, and glycosylated hemoglobin (HbA1c) testing

0Percent

2010Target

4020

Total

Hispanic

Asian

Obj. 4-8b

American Indian

Black

White

Native Hawaiian

Medical Treatment for Persons with Diabetes and Chronic Kidney Disease

Note: American Indian includes Alaska Native; Native Hawaiian includes other Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: USRDS.

*

3010

*

*

*

2000

0Percent

2010Target

4020

Total

Hispanic

Asian

Obj. 4-8b

American Indian

Black

White

Native Hawaiian

Medical Treatment for Persons with Diabetes and Chronic Kidney Disease

Note: American Indian includes Alaska Native; Native Hawaiian includes other Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: USRDS.

*

3010

*

*

*

Medical treatment includes the use of angiotensin converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARB)200

0

Progress review data and slides

are available on the web at:

http://www.cdc.gov/nchs/hphome.htmhttp://www.cdc.gov/nchs/hphome.htm